tirzepatide cardiovascular outcomes trial results july 2025 🚨 Breaking News: Real-World Data Comparing Semaglutide and on Tirzepatide demonstrates cardiovascular protection in

doi: 10.1038/s41574-019-0176-8 9 MaCAvenellABollandMHudsonJStewartFRobertsonCet al

Both are synthetic incretin peptides with substantial published phase 2 data

Variants in genes like FTO (rs9939609), MC4R (rs17782313) (rs6923761) influence appetite regulation, metabolic rate, and how your body responds to GLP-1 signaling

This means they often appear or worsen after a dose increase, but tend to settle as your body adjusts over time

Although there are some adverse effects, they are often minor and go away in a few weeks

Following your weight loss program, the recovery process is carefully tailored to ensure your comfort and well-being